Primary Versus Interval Cytoreductive Surgery in Treatment of Advanced Ovarian Cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Primary Versus Interval Cytoreductive Surgery in Treatment of Advanced Ovarian Cancer ; volume:28 ; number:01 ; year:2007 ; pages:14-19
Indian journal of medical & paediatric oncology ; 28, Heft 01 (2007), 14-19
- Contributor
-
LONE, ABDUL RASHID
AHMAD, MUSHTAQ
KOUR, SANDEEP
AZIZ, SHEIKH AEJAZ
BANDAY, MANZOOR A.
JEELANI, SAMOON
- DOI
-
10.1055/s-0041-1733198
- URN
-
urn:nbn:de:101:1-2022051210113402179126
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- LONE, ABDUL RASHID
- AHMAD, MUSHTAQ
- KOUR, SANDEEP
- AZIZ, SHEIKH AEJAZ
- BANDAY, MANZOOR A.
- JEELANI, SAMOON
Other Objects (12)
Significance of cholecystectomy in cytoreductive surgery for advanced ovarian cancer
Fifth annual workshop of cytoreductive surgery for advanced ovarian cancer and peritoneal surface malignancies
Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients: a pilot study
Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
Changes in peripheral lymphocyte populations in patients with advanced/recurrent ovarian cancer undergoing splenectomy during cytoreductive surgery
Clinical outcomes of cytoreductive surgery and HIPEC in advanced and recurrent epithelial ovarian cancers with peritoneal carcinomatosis
Clinical outcomes of cytoreductive surgery and HIPEC in advanced and recurrent epithelial ovarian cancers with peritoneal carcinomatosis
Prognostic analysis of peritoneal washing cytology during interval debulking surgery in advanced ovarian cancer
Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique
Neoadjuvant chemotherapy followed by interval debulking surgery for advanced epithelial ovarian cancer: GOTIC-019 study
The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
Cytoreductive Surgery and HIPEC for Regionally Advanced Gallbladder Cancer: a Case Report
Significance of cholecystectomy in cytoreductive surgery for advanced ovarian cancer
Fifth annual workshop of cytoreductive surgery for advanced ovarian cancer and peritoneal surface malignancies
Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients: a pilot study
Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
Changes in peripheral lymphocyte populations in patients with advanced/recurrent ovarian cancer undergoing splenectomy during cytoreductive surgery
Clinical outcomes of cytoreductive surgery and HIPEC in advanced and recurrent epithelial ovarian cancers with peritoneal carcinomatosis
Clinical outcomes of cytoreductive surgery and HIPEC in advanced and recurrent epithelial ovarian cancers with peritoneal carcinomatosis
Prognostic analysis of peritoneal washing cytology during interval debulking surgery in advanced ovarian cancer
Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique
Neoadjuvant chemotherapy followed by interval debulking surgery for advanced epithelial ovarian cancer: GOTIC-019 study
The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
Cytoreductive Surgery and HIPEC for Regionally Advanced Gallbladder Cancer: a Case Report
Significance of cholecystectomy in cytoreductive surgery for advanced ovarian cancer
Fifth annual workshop of cytoreductive surgery for advanced ovarian cancer and peritoneal surface malignancies
Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients: a pilot study
Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
Changes in peripheral lymphocyte populations in patients with advanced/recurrent ovarian cancer undergoing splenectomy during cytoreductive surgery
Clinical outcomes of cytoreductive surgery and HIPEC in advanced and recurrent epithelial ovarian cancers with peritoneal carcinomatosis
Clinical outcomes of cytoreductive surgery and HIPEC in advanced and recurrent epithelial ovarian cancers with peritoneal carcinomatosis
Prognostic analysis of peritoneal washing cytology during interval debulking surgery in advanced ovarian cancer
Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique
Neoadjuvant chemotherapy followed by interval debulking surgery for advanced epithelial ovarian cancer: GOTIC-019 study
The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis